Hep Email Update Liver Stiffness After Hep C Treatment Linked to Decompensated Cirrhosis No significant links were found between liver stiffness prior to antiviral treatment and cirrhosis, liver cancer or transplants or death. Advertisement Consumption of High Fructose Drives Fatty Liver Disease In mice, excessive fructose can lead to a leaky gut and trigger liver inflammation. Fourth Large-Scale COVID-19 Vaccine Trial Begins in the United States The trial is evaluating an investigational vaccine from Janssen that may require only one shot. Abnormal Liver Tests Linked to Worse COVID-19 Outcomes The prevalence of abnormal liver tests in people hospitalized with COVID-19 is higher than previously found. #Coronavirus Get the latest updates! Positively Empowering In honor of Hep commemorating 10 years, we are spotlighting 10 inspiring activists: Gloria Searson keeps changing the way people think about hep C. Advertisement Treatment News Consumption of High Fructose Drives Fatty Liver Disease Liver Stiffness After Hep C Treatment Linked to Decompensated Cirrhosis Cotadutide Improves NASH Biomarkers in Overweight People With Diabetes Abnormal Liver Tests Linked to Worse COVID-19 Outcomes Many People on Medicaid and Prisoners Still Lack Access to Hepatitis C Treatment Aldafermin Improves Fibrosis in People With NASH Features Trump’s Executive Order on Preexisting Conditions Lacks Teeth, Experts Say Positively Empowering Who Is Most Susceptible to COVID-19? Perseverance Continued Turning Anger Into Action Living to Tell Treatment News Consumption of High Fructose Drives Fatty Liver Disease Liver Stiffness After Hep C Treatment Linked to Decompensated Cirrhosis Cotadutide Improves NASH Biomarkers in Overweight People With Diabetes Abnormal Liver Tests Linked to Worse COVID-19 Outcomes Many People on Medicaid and Prisoners Still Lack Access to Hepatitis C Treatment Aldafermin Improves Fibrosis in People With NASH Features Trump’s Executive Order on Preexisting Conditions Lacks Teeth, Experts Say Positively Empowering Who Is Most Susceptible to COVID-19? Perseverance Continued Turning Anger Into Action Living to Tell

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: